Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Kedudukan dalam Saham
#4602
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Harga Saham
$3.28
Modal Pasaran
$3.32B
Perubahan (1 hari)
4.19%
Perubahan (1 tahun)
-10.41%
Negara
CN
Perdagangan Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Kategori
Healthcare
Hasil untuk Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Hasil pada Jun 2026 TTM: $886.77M
Menurut laporan kewangan terkini daripada Jiangsu Nhwa Pharmaceutical Co., Ltd., hasil semasa syarikat (TTM) ialah $886.77M. Pada tahun 2023, syarikat memperoleh hasil sebanyak $712.22M peningkatan berbanding hasil pada tahun 2022 iaitu $623.16M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Jiangsu Nhwa Pharmaceutical Co., Ltd. dari 2005 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $886.77M | 13.60% |
| 2024 | $780.59M | 9.60% |
| 2023 | $712.22M | 14.29% |
| 2022 | $623.16M | 0.64% |
| 2021 | $619.21M | 20.34% |
| 2020 | $514.54M | -13.65% |
| 2019 | $595.88M | 6.24% |
| 2018 | $560.89M | 7.53% |
| 2017 | $521.61M | 20.00% |
| 2016 | $434.66M | 2.02% |
| 2015 | $426.03M | 5.50% |
| 2014 | $403.84M | 9.55% |
| 2013 | $368.64M | 15.95% |
| 2012 | $317.92M | 26.25% |
| 2011 | $251.82M | 27.80% |
| 2010 | $197.05M | 21.09% |
| 2009 | $162.72M | 16.57% |
| 2008 | $139.59M | 26.64% |
| 2007 | $110.22M | 23.66% |
| 2006 | $89.14M | 12.63% |
| 2005 | $79.14M | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 645.58% |
IN
|
